Search Results

Search Results for "diabetes"

• FDA doing reassessment of diabetes drug
  The Wall Street Journal says the U.S. Food and Drug Administration is doing a reassessment of Avandia – a diabetes drug manufactured by GlaxoSmithKline that was once regarded as a blockbuster in the pharmaceutical market. In 2007, a study linked Avandia to heart attacks. In 2010, the FDA imposed r...

• Diabetes drug maker allegedly hid cancer risk
  A lawsuit has gone to jury trial in Los Angeles, alleging that the manufacturer of the diabetes drug Actos concealed its cancer risks, Bloomberg reports. The plaintiff’s lawyer claims that internal studies by Takeda, Asia’s biggest drug manufacturer, uncovered Actos’s links to bladder cancer a...

• FDA approves new diabetes drug
  The U.S. Food and Drug Administration has approved Johnson & Johnson’s drug Invokana, which will be used to treat type 2 diabetes. According to the New York Times, Invokana is the first of a new class of diabetes medication. It causes blood sugar to be excreted in the urine, as opposed to many...

• Market keeping a close eye on new diabetes drug
  A story in Forbes says medical professionals and industry analysts are both keeping a close eye on Johnson & Johnson’s Invokana, newly approved by the U.S. Food and Drug Administration. It’s the first to be approved among a new class of medications that treat type 2 diabetes by reducing bloo...

• Hormone levels may play role in diabetes
  Researchers at Brigham and Women’s Hospital in Boston have released a study concluding that low levels of the hormone melatonin may play a role in developing type 2 diabetes, USA Today reports. They found that women with low levels of melatonin at night had twice the risk of developing type 2 diab...

• Investors should be cautious about diabetes drug
  A newly approved diabetes drug from Johnson & Johnson may have the potential to be very profitable, given skyrocketing diabetes rates in the Unites States. But a story on the blog Seeking Alpha cautions investors against being too optimistic, given the disappointing results of other diabetes dru...

• FDA examines link between diabetes drugs, cancer
  The U.S. Food and Drug Administration is examining unpublished findings by a group of academic researchers, which suggest a potential link between newer diabetes drugs and pancreatic cancer. Among the drugs being investigated are Merck’s Januvia and Bristol-Myers Squibb’s Byetta, Bloomberg repor...

• Study says USA’s diabetes costs are $245B
  A recent study has put America’s health care and work-related costs related to diabetes at $245 billion in 2012, according to a story in USA Today. That represents a 41 percent increase from 2007, when the cost was $174 billion. Diabetes, a disease in which blood glucose levels are above normal, i...

• Diabetes increasing at alarming rate
  A story in the Huffington Post says there’s been an alarming increase in diabetes in recent years. Officials with the U.S. Centers for Disease Control and Prevention project that as many as one in three Americans could have diabetes by 2050 if current trends continue. According to the article, CDC...

• Diabetes drug could be a ‘blockbuster’
  A blog post on Forbes deals with Johnson & Johnson’s type 2 diabetes drug Canagliflozin, which is expected to receive FDA approval soon and which the report describes as having “blockbuster potential.” According to the report, Canagliflozin proved effective at lowering blood glucose levels...